You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DLBCL (Diffuse Large B-cell lymphoma)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
May 16, 2023

Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
  • (no location specified)
Sep 5, 2023

Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

Recruiting
  • Diffuse Large B-cell Lymphoma Recurrent
  • Diffuse Large B Cell Lymphoma Refractory
  • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 12, 2023

Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma:

Completed
  • Diffuse Large B-cell Lymphoma
    • East Hanover, New Jersey
      Novartis
    Jun 16, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    DLBCL Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • (no location specified)
    Jul 11, 2023

    Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 18, 2023

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Lymphoma Trial in Shanghai (Other)

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Lymphoma
    • Other
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Sep 6, 2023

    Frontline of ASCT in High-risk DLBCL

    Recruiting
    • Diffuse Large B Cell Lymphoma
      • Beijing, Beijing, China
        Peking University People's Hospital
      Apr 26, 2023

      Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

      Recruiting
      • Diffuse Large B Cell Lymphoma，DLBCL
      • PM 8.4 mg/m2
      • PM 11.2 mg/m2
      • Chengdu, Sichuan, China
        West China Hospital Sichuan University
      Jan 15, 2023

      Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

      Not yet recruiting
      • Diffuse Large B-cell Lymphoma
      • (no location specified)
      Mar 23, 2023

      Including miRNA-based Tumor Signatures in Diffuse Large B Cell

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • Relapsed Non-Hodgkin Lymphoma
      • no intervention (observational study)
      • Napoli, Italy
      • +2 more
      Feb 17, 2023

      DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)

      Recruiting
      • DLBCL - Diffuse Large B Cell Lymphoma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 19, 2023

      Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Dec 12, 2022

      Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

      Recruiting
      • Diffuse Large B-cell Lymphoma (DLBCL)
      • Westbury, New York
        Clinical Research Alliance Inc
      Oct 13, 2023

      Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Low-Dose Decitabine plus anti-PD-1
      • Beijing, Beijing, China
        ChinaPLAGH
      Apr 18, 2023

      Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

      Recruiting
      • Diffuse Large B Cell Lymphoma
        • Salvador, Bahia, Brazil
        • +9 more
        Jul 24, 2023

        Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

        Recruiting
        • Diffuse Large B-cell Lymphoma
        • Metabolically Armed CD19 CAR-T cells
        • Hangzhou, Zhejiang, China
          The first affiliated hospital of medical college of zhejiang uni
        Nov 1, 2023

        Communication Training Intervention for Large B-Cell Lymphoma

        Recruiting
        • Lymphoma, B-Cell
        • +5 more
        • Hematolo-GIST Training
        • Participants Appointment
        • New York, New York
        • +2 more
        Jul 3, 2023

        Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma
        • Shenyang, Liaoning, China
          Xing Xiaojing
        Jun 1, 2023

        Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

        Active, not recruiting
        • Diffuse Large B Cell Lymphoma
        • +2 more
        • Duarte, California
        • +2 more
        Nov 10, 2022

        Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma

        Completed
        • Diffuse Large B-cell Lymphoma (DLBCL)
        • CAR-T
        • Allo-HSCT cohort
        • East Hanover, New Jersey
          Novartis Investigative Site
        Jun 29, 2022

        Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

        Active, not recruiting
        • Diffuse Large B-cell Lymphoma
        • Shanghai, Shanghai, China
          Shanghai Ruijin Hospital
        Dec 1, 2022

        Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Suzhou, Jiangsu, China
          the First Affiliated Hospital of Soochow University
        Apr 10, 2023